Ahmed MA, Naus M, Singer J, et al. Investigating the association of receipt of seasonal influenza vaccine with occurrence of anesthesia/paresthesia and severe headaches, Canada 2012/13–2016/17, the Canadian Vaccine Safety Network. Vaccine 2020 (published online Mar 27)
Alessandrini V, Anselem O, Girault A, et al. Does the availability of influenza vaccine at prenatal care visits and of immediate vaccination improve vaccination coverage of pregnant women? PLOS One 2019 Aug 1;14(8):e0220705
Anderson ML, Dobkin C, Gorry D. The effect of influenza vaccination for the elderly on hospitalization and mortality: an observational study with a regression discontinuity design. Ann Intern Med 2020 (published online Mar 3)
Arya DP, Said MA, Izurieta HS, et al. Surveillance for Guillain-Barre syndrome after 2015-2016 and 2016-2017 influenza vaccination of Medicare beneficiaries. Vaccine 2019 (published online Sep 9)
Balasubramani GK, Nowalk MP, Sax TM, et al. Influenza vaccine effectiveness among outpatients in the US Influenza Vaccine Effectiveness Network by study site 2011‐2016. Influenza Other Respir Viruses 2020 (published online Apr 16)
Baum U, Kulathinal S, Auranen K, et al. Effectiveness of two influenza vaccines in nationwide cohorts of Finnish two-year-old children in the seasons 2015/16-2017/18. Clin Infect Dis 2020 (published online Jan 19)
Blyth CC, Cheng AC, Crawford NW, e al. The impact of new universal child influenza programs in Australia: vaccine coverage, effectiveness and disease epidemiology in hospitalised children in 2018. Vaccine 2020 Mar 17;38(13):2799-87
Boddington NL, Warburton F, Zhao H, et al. Influenza vaccine effectiveness against hospitalisation due to laboratory-confirmed influenza in children in England in the 2015-2016 influenza season — a test-negative case-control study. Epidemiol Infect 2019 (published online May 30)
Braeye T, Emborg HD, Llorente-Garcia A, et al. Age-specific vaccination coverage estimates for influenza, human papillomavirus and measles containing vaccines from seven population-based healthcare databases from four EU countries – The ADVANCE project. Vaccine 2020 (published online Mar 12)
Bresee JS, Lafond KE, McCarron M, et al. The partnership for influenza vaccine introduction (PIVI): supporting influenza vaccine program development in low and middle-income countries through public-private partnerships. Vaccine 2019 (published online Jul 6)
Castilla J, Portillo ME, Casado I, et al. Effectiveness of the current and prior influenza vaccinations in northern Spain, 2018-2019. Vaccine 2020 (published online Jan 22)
Castillejos M, Cabello-Gutierrez C, Choreno-Parra JA, et al. High performance of rapid influenza diagnostic test and variable effectiveness of influenza vaccines in Mexico. Int J Infect Dis 2019 (published online Sep 7)
Chang LJ, Meng Y, Janosczyk J, et al. Safety and immunogenicity of high-dose quadrivalent influenza vaccine in adults >65 years of age: a phase 3 randomized clinical trial. Vaccine 2019 (published online Aug 17)
Christiansen CF, Thomsen RW, Schmidt M, et al. Influenza vaccination and 1-year risk of myocardial infarction, stroke, heart failure, pneumonia, and mortality among intensive care unit survivors aged 65 years or older: a nationwide population-based cohort study. Intensive Care Med 2019 Jul;45(7):957-67
Chua H, Chiu SS, Chan ELY, et al. Effectiveness of partial and full influenza vaccination in children aged <9 years in Hong Kong, 2011-2019. J Infect Dis 2019 (published online Jul 9)
Chung JR, Flannery B, Gaglani M, et al. Patterns of influenza vaccination and vaccine effectiveness among young US children who receive outpatient care for acute respiratory tract illness. JAMA Pediatr 2020 (published online May 4)
Costantino C, Restivo V, Amodio E, et al. A mid-term estimate of 2018/2019 vaccine effectiveness to prevent laboratory confirmed A(H1N1)pdm09 and A(H3N2) influenza cases in Sicily (Italy). Vaccine 2019 (published online Aug 16)
Cowling BJ, Perera RAPM, Valkenburg SA, et al. Comparative immunogenicity of several enhanced influenza vaccine options for older adults: a randomized, controlled trial. Clin Infect Dis 2019 (published online Dec 12)
Cowling BJ, Thompson MG, Ng TW, et al. Comparative reactogenicity of enhanced influenza vaccines in older adults. J Infect Dis 2020 (published online May 14)
Cross JW, Joy M, McGee C, et al. Adverse events of interest vary by influenza vaccine type and brand: sentinel network study of eight seasons (2010–2018). Vaccine 2020 May 8;38(22):3869-80
Cutrell JB, Drechsler H, Bedimo R, et al. Statin use and medically attended acute respiratory illness among influenza vaccine recipients. Vaccine 2019 Oct 16;37(44):7607-13
Dawood FS, Chung JR, Kim SS, et al. Interim estimates of 2019-20 seasonal influenza vaccine effectiveness ─ United States, February 2020. MMWR 2020 Feb 21;69(7):177-82
